Results 171 to 180 of about 46,553 (219)

Inflammatory-Demyelinating Polyneuropathies

Neurologic Clinics, 1992
Recent advances in the pathogenesis and management of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) are presented. These diseases are both diagnosable and treatable. The role of Campylobacter infection preceding GBS and the use of intravenous immunoglobulin to treat CIDP are discussed.
openaire   +2 more sources

Chronic inflammatory demyelinating polyneuropathy

Current Opinion in Neurology, 2007
Purpose of review As a syndrome with typical and atypical cases, chronic inflammatory demyelinating polyneuropathy (CIDP) has been a difficult disorder to diagnose and treat. The pathophysiologic basis for CIDP has not been established, contributing to the challenges in dealing with these patients.
openaire   +3 more sources

Subacute inflammatory demyelinating polyneuropathy

Neurology, 2003
To report the clinical, electrophysiologic, and histologic characteristics of subacute inflammatory demyelinating polyneuropathy (SIDP) and to present the diagnostic criteria of this disease.For a diagnosis of "definite SIDP," there were four mandatory criteria: 1) progressive motor and/or sensory dysfunction consistent with neuropathy in more than one
S J, Oh, K, Kurokawa, D F, de Almeida, H F, Ryan, G C, Claussen   +4 more
openaire   +2 more sources

Chronic inflammatory demyelinating polyneuropathy

Neuromuscular Disorders, 2006
Chronic inflammatory demyelinative polyneuropathy (CIDP) is an acquired neuropathy, presumably of immunological origin. Its clinical presentation and course are extremely variable. CIDP is one of the few peripheral neuropathies amenable to treatment. Typical cases associate progressive or relapsing-remitting motor and sensory deficit with increased CSF
openaire   +2 more sources

Diagnosis of chronic inflammatory demyelinating polyneuropathy

Muscle & Nerve, 2022
AbstractChronic inflammatory demyelinating polyneuropathy (CIDP) is a chronic immune‐mediated peripheral form of polyneuropathy. No reliable diagnostic biomarkers are available by which to make the diagnosis of CIDP. As a result, diagnosis of the condition can be challenging.
Jeffrey A. Allen, Richard A. Lewis
openaire   +2 more sources

Chronic inflammatory demyelinative polyneuropathy

2013
Chronic inflammatory demyelinative polyneuropathy (CIDP) is an acquired polyneuropathy presumably of immunological origin. It is characterized by a progressive or a relapsing course with predominant motor deficit. The diagnosis rests on the association of non-length-dependent predominantly motor deficit following a progressive or a relapsing course ...
Said, Gérard, Krarup, Christian
openaire   +3 more sources

Chronic inflammatory demyelinating polyneuropathy

Current Treatment Options in Neurology, 1999
Treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) requires long-term immunomodulatory therapy, which has potential side effects. Before such therapy is instituted, a firm diagnosis of CIDP must be established. Prednisone, plasma exchange (PE), and intravenous immunoglobulin (IVIG) are all proven first-line therapies for CIDP that ...
, Gorson, , Chaudhry
openaire   +2 more sources

Clinical neurophysiology of demyelinating polyneuropathy

2019
Demyelinating neuropathies are remarkably varied in their clinical characteristics: In etiology they may be inherited or acquired, in their time course, acute or chronic, and in their distribution, multifocal or generalized. They present with phenotypes that range from an indolent disorder that begins in childhood and progresses slowly over decades (as
Michael P, Bowley, David A, Chad
openaire   +2 more sources

Chronic Acquired Demyelinating Polyneuropathies

Seminars in Neurology, 2008
Several entities can be put under the heading of chronic acquired demyelinating polyneuropathy. Future research will hopefully provide a greater understanding of pathophysiology, which may suggest the ideal way to classify and manage these patients. In the meantime, it is reasonable and useful to use clinical, laboratory, and electrodiagnostic data to ...
openaire   +2 more sources

Fatigue in chronic inflammatory demyelinating polyneuropathy

Muscle & Nerve, 2020
AbstractIntroductionIn this study we aimed to better understand fatigue in chronic inflammatory demyelinating polyneuropathy (CIDP) as it relates to disease activity status.MethodsPatients with probable or definite CIDP were stratified into active CIDP or CIDP in remission.
Karissa L, Gable, Hrayr, Attarian, Jeffrey A, Allen   +2 more
openaire   +2 more sources